Skip to main content

Oncology

Bibliographic References tagged with Oncology

Not finding what you're looking for? Try using Advanced Search.
Not finding what you're looking for? Try using Advanced Search.
Suwajanakorn, Lane, Go, Hartley, Oxenreiter, Wu, Gragoudas E, Sullivan, Montazeri, Kim I. Impact of gene expression profiling on diagnosis and survival after metastasis in patients with uveal melanoma.
Melanoma Res. 2024; PMID: 38578293
Suwajanakorn, Lane, Go, Hartley, Oxenreiter, Wu, Gragoudas E, Sullivan, Montazeri, Kim I. Impact of gene expression profiling on diagnosis and survival after metastasis in patients with uveal melanoma.
Melanoma Res. 2024; PMID: 38578293
Kim E, Lee J, Ganga A, Barton A, Rana V, Araia E, Adriance W, Wang R, Somsasundar P, Kim L. Analysis of Uveal Melanoma 5-Year Survival Rates by Medicaid Status: A Nationwide Analysis.
Ophthalmic Epidemiol. 2023;:1–7. PMID: 37964586
Kim E, Lee J, Ganga A, Barton A, Rana V, Araia E, Adriance W, Wang R, Somsasundar P, Kim L. Analysis of Uveal Melanoma 5-Year Survival Rates by Medicaid Status: A Nationwide Analysis.
Ophthalmic Epidemiol. 2023;:1–7. PMID: 37964586
Ocul Immunol Inflamm. 2023;31(8):1669–1673. PMID: 35914291
Ocul Immunol Inflamm. 2023;31(8):1669–1673. PMID: 35914291
Goenka A, Khan F, Verma B, Sinha P, Dmello C, Jogalekar M, Gangadaran P, Ahn BC. Tumor microenvironment signaling and therapeutics in cancer progression.
Cancer Commun (Lond). 2023;43(5):525–561. PMID: 37005490
Goenka A, Khan F, Verma B, Sinha P, Dmello C, Jogalekar M, Gangadaran P, Ahn BC. Tumor microenvironment signaling and therapeutics in cancer progression.
Cancer Commun (Lond). 2023;43(5):525–561. PMID: 37005490
Trofimov A, Aronow M, Bussière M, Gragoudas E, Keane F, Kim I, Shih H, Bhagwat M. In Reply to Elmali and Yazici.
Int J Radiat Oncol Biol Phys. 2023;115(3):810–811. PMID: 36725170
Trofimov A, Aronow M, Bussière M, Gragoudas E, Keane F, Kim I, Shih H, Bhagwat M. In Reply to Elmali and Yazici.
Int J Radiat Oncol Biol Phys. 2023;115(3):810–811. PMID: 36725170
Uner O, Aronow M, Mruthyunjaya P, Materin M, Stacey A, Wilson M, Afshar A, Skalet A. Uveal Melanoma and the IRIS® Registry (Intelligent Research in Sight): A Pilot Analysis and Future Directions.
Ophthalmol Retina. 2023;7(3):284–286. PMID: 36522810
Uner O, Aronow M, Mruthyunjaya P, Materin M, Stacey A, Wilson M, Afshar A, Skalet A. Uveal Melanoma and the IRIS® Registry (Intelligent Research in Sight): A Pilot Analysis and Future Directions.
Ophthalmol Retina. 2023;7(3):284–286. PMID: 36522810
Correa V, Efstathiou N, Ntentakis D, Yu Z, Narimatsu T, Gragoudas E, Kim I, Vavvas D. The NLRP3 inflammasome - interleukin 1β axis in uveal melanoma.
FEBS Open Bio. 2023;13(3):545–555. PMID: 36707938
Correa V, Efstathiou N, Ntentakis D, Yu Z, Narimatsu T, Gragoudas E, Kim I, Vavvas D. The NLRP3 inflammasome - interleukin 1β axis in uveal melanoma.
FEBS Open Bio. 2023;13(3):545–555. PMID: 36707938
Farhat W, Yeung V, Ross A, Kahale F, Boychev N, Kuang L, Chen L, Ciolino J. Advances in biomaterials for the treatment of retinoblastoma.
Biomater Sci. 2022;10(19):5391–5429. PMID: 35959730
Farhat W, Yeung V, Ross A, Kahale F, Boychev N, Kuang L, Chen L, Ciolino J. Advances in biomaterials for the treatment of retinoblastoma.
Biomater Sci. 2022;10(19):5391–5429. PMID: 35959730
Franco J, Liu K, Ioakeim-Ioannidou, Davila J, Chen, Kim I, Gragoudas E, Mukai, MacDonald S. Low-dose proton radiotherapy for pediatric choroidal hemangioma: A case series.
Pediatr Blood Cancer. 2022;
Franco J, Liu K, Ioakeim-Ioannidou, Davila J, Chen, Kim I, Gragoudas E, Mukai, MacDonald S. Low-dose proton radiotherapy for pediatric choroidal hemangioma: A case series.
Pediatr Blood Cancer. 2022;